Literature DB >> 16722967

Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade.

J Mladenovic1, T Pekmezovic, S Todorovic, V Rakocevic-Stojanovic, D Savic, S Romac, S Apostolski.   

Abstract

The purpose of this investigation was to determine survival and mortality in patients with myotonic dystrophy type 1 (DM1) in the Belgrade population within the period from 1983 to 2002. Data of a number of diagnosed DM1 patients with their demographic, clinical and genetic characteristics were gathered from hospital records in all neurologic institutions in Belgrade for the period 1983-2002. Death certificates were reviewed to determine the cause of death. Survival analysis by life table method and Cox proportional hazard model was performed. Within the observed period, in the population of Belgrade, 15 fatal outcomes among 101 patients with DM1 were registered. Average DM1 mortality rate was 0.5/1,000,000 (95% CI 0.3-0.8), and standardized mortality ratio (SMR) was 5.3. A significant inverse correlation was found between age at onset of DM1 and CTG repeats (P=0.023). The cumulative probability of 15-year survival for DM1 patients in Belgrade was 49+/-5% (48+/-2% for males and 50+/-7% for females). Younger age at onset was a significant unfavorable prognostic factor (hazard ratio=4.2; P=0.012).

Entities:  

Mesh:

Year:  2006        PMID: 16722967     DOI: 10.1111/j.1468-1331.2006.01261.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Survival patterns and cancer determinants in families with myotonic dystrophy type 1.

Authors:  A F Best; J E Hilbert; L Wood; W B Martens; N Nikolenko; C Marini-Bettolo; H Lochmüller; P S Rosenberg; R T Moxley; M H Greene; S M Gadalla
Journal:  Eur J Neurol       Date:  2018-09-16       Impact factor: 6.089

2.  Predictors of clinical outcomes and hospital resource use of children after tracheotomy.

Authors:  Jay G Berry; Dionne A Graham; Robert J Graham; Jing Zhou; Heather L Putney; Jane E O'Brien; David W Roberson; Don A Goldmann
Journal:  Pediatrics       Date:  2009-07-13       Impact factor: 7.124

3.  The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications.

Authors:  Bénédicte Lallemand; Nicolas Clementy; Anne Bernard-Brunet; Bertrand Pierre; Philippe Corcia; Laurent Fauchier; Martine Raynaud; Sybille Pellieux; Dominique Babuty
Journal:  Heart       Date:  2011-10-29       Impact factor: 5.994

4.  Hypogonadism and erectile dysfunction in myotonic dystrophy type 1.

Authors:  Stojan Peric; Tanja Nisic; Milena Milicev; Ivana Basta; Ivan Marjanovic; Marina Peric; Dragana Lavrnic; Vidosava Rakocevic Stojanovic
Journal:  Acta Myol       Date:  2013-10

5.  Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.

Authors:  Mark J Hamilton; Yvonne Robb; Sarah Cumming; Helen Gregory; Alexis Duncan; Monika Rahman; Anne McKeown; Catherine McWilliam; John Dean; Alison Wilcox; Maria E Farrugia; Anneli Cooper; Josephine McGhie; Berit Adam; Richard Petty; Cheryl Longman; Iain Findlay; Alan Japp; Darren G Monckton; Martin A Denvir
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

6.  Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1.

Authors:  Stephan Wenninger; Sarah A Cumming; Kristina Gutschmidt; Kees Okkersen; Aura Cecilia Jimenez-Moreno; Ferroudja Daidj; Hanns Lochmüller; Fiona Hogarth; Hans Knoop; Guillaume Bassez; Darren G Monckton; Baziel G M van Engelen; Benedikt Schoser
Journal:  Neurol Genet       Date:  2021-03-09

7.  Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1.

Authors:  Ji Yoon Han; Woori Jang; Joonhong Park
Journal:  Genes (Basel)       Date:  2022-08-17       Impact factor: 4.141

Review 8.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

9.  Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.

Authors:  Shahinaz M Gadalla; Ruth M Pfeiffer; Sigurdur Y Kristinsson; Magnus Björkholm; James E Hilbert; Richard T Moxley; Ola Landgren; Mark H Greene
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.